Human induced pluripotent stem cells can reach complete terminal maturation: In vivo and in vitro evidence in the erythropoietic differentiation model

Haematologica

Volumn 97, Issue 12, 2012, Pages 1795-1803

  Kobar, Ladan ^a,b   Yates, Frank ^c,d   Oudrhiri, Noufissa ^c,n   Francina, Alain ^e   Kiger, Laurent ^f   Mazurier, Christelle ^a,b,g   Rouzbeh, Shaghayegh ^a,b   El Nemer, Wassim ^h,i,j   Hebert, Nicolas ^a,b,g   Giarratana, Marie Catherine ^a,b   François, Sabine ^k   Chapel, Alain ^k   Lapillonne, Hélène ^a,b,l   Luton, Dominique ^m   Bennaceur Griscelli, Annelise ^c,n   Douay, Luc ^a,b,g,l  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c INSERM   (France)

^d The Higher Institute of Biotechnologies of Paris   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f BICÊTRE HOSPITAL   (France)

^g ETABLISSEMENT FRANÇAIS DU SANG   (France)

^h hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

ⁱ INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m BEAUJON HOSPITAL   (France)

ⁿ HÔPITAL PAUL BROUSSE   (France)

more..

Author keywords

Erythropoietic differentiation; Human induced pluripotent stem cells; Terminal maturation

Indexed keywords

CD36 ANTIGEN; CD71 ANTIGEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A; HEMOGLOBIN F; PYRUVATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL THERAPY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE DEFORMABILITY; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; OXYGEN TRANSPORT; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; STAINING;

ADULT; AMNIOTIC FLUID; ANEMIA, SICKLE CELL; ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; ERYTHROCYTES; ERYTHROPOIESIS; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; OXYGEN;

EID: 84870429821     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.055566     Document Type: Article

References (37)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72.
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-20.
3. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136(5):964-77.
4. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104 (4):e30-41.
5. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010;95(10):1651-9.
6. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009;114(27):5473-80.
7. Takenaka C, Nishishita N, Takada N, Jakt LM, Kawamata S. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol. 2010;38 (2):154-62.
8. Mitjavila-Garcia MT, Bonnet ML, Yates F, Haddad R, Oudrhiri N, Feraud O, et al. Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells. J Mol Cell Biol. 2010;2(5):291-8.
9. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321(5893):1218-21.
10. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134(5):877-86.
11. Mazurier C, Douay L, Lapillonne H. Red blood cells from induced pluripotent stem cells: hurdles and developments. Curr Opin Hematol. 2011;18(4):249-53.
12. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells. 2009;27(3):559-67.
13. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011;117(14): e109-19.
14. Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, et al. Generation of iPSCs from cultured human malignant cells. Blood. 2010;115(20):4039-42.
15. Peyrard T, Bardiaux L, Krause C, Kobari L, Lapillonne H, Andreu G, et al. Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges. Transfus Med Rev. 2011;25(3):206-16.
16. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318(5858):1920-3.
17. Sebastiano V, Maeder ML, Angstman JF, Haddad B, Khayter C, Yeo DT, et al. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells. 2011;29(11):1717-26.
18. Zou J, Mali P, Huang X, Dowey SN, Cheng L. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood. 2011;118(17):4599-608.
19. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990;40:63-280.
20. Segal JB, Strouse JJ, Beach MC, Haywood C, Witkop C, Park H, et al. Hydroxyurea for the treatment of sickle cell disease. Evid Rep Technol Assess (Full Rep). 2008(165):1-95.
21. Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol. 2000;28(12):1470-80.
22. Zanella-Cleon I, Becchi M, Lacan P, Giordano PC, Wajcman H, Francina A. Detection of a thalassemic alpha-chain variant (Hemoglobin Groene Hart) by reversed-phase liquid chromatography. Clin Chem. 2008;54(6):1053-9.
23. Riou J, Godart C, Hurtrel D, Mathis M, Bimet C, Bardakdjian-Michau J, et al. Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem. 1997;43(1):34-9.
24. El Nemer W, Gane P, Colin Y, Bony V, Rahuel C, Galacteros F, et al. The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem. 1998;273(27):16686-93.
25. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74.
26. Jansen G, Koenderman L, Rijksen G, Cats BP, Staal GE. Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol. 1985;20(3):203-15.
27. Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood. 1975;46(5):671-82.
28. Johnson RM, Ravindranath Y. Osmotic scan ektacytometry in clinical diagnosis. J Pediatr Hematol Oncol. 1996;18(2):122-9.
29. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods. 2000;243(1-2):147-54.
30. Neildez-Nguyen TM, Wajcman H, Marden MC, Bensidhoum M, Moncollin V, Giarratana MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20(5):467-72.
31. Giarratana MC, Rouard H, Dumont A, Kiger L, Safeukui I, Le Pennec PY, et al. Proof of principle for transfusion of in vitro generated red blood cells. Blood. 2011; 118(19):5071-9.
32. Hayakawa J, Hsieh MM, Anderson DE, Phang O, Uchida N, Washington K, et al. The assessment of human erythroid output in NOD/SCID mice reconstituted with human hematopoietic stem cells. Cell Transplant. 2010;19(11):1465-73.
33. Wojda U, Noel P, Miller JL. Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. Blood. 2002;99(8):3005-13.
34. Qiu C, Olivier EN, Velho M, Bouhassira EE. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood. 2008;111(4):2400-8.
35. Chang KH, Huang A, Hirata RK, Wang PR, Russell DW, Papayannopoulou T. Globin phenotype of erythroid cells derived from human induced pluripotent stem cells. Blood. 2010;115(12):2553-4.
36. Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008; 112(12):4475-84.
37. Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus Clin Biol. 2008;15 (1-2):39-50.